CLINICAL_TRIALS
trial_result
· 2025-03-28
Clinical Trial Update: Safety and Feasibility of Using Cerebrolysin in the Treatment of Primary Intracerebral Hemorrhage - a Prospective Randomized Open Blinded End-point Trial [Phase 4]
Summary
Phase 4 prospective randomized blinded-endpoint trial assessing the safety and feasibility of Cerebrolysin for treating primary intracerebral hemorrhage; the st…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cardinal Stefan Wyszynski University | Conditions: Intracerebral Hemorrhage, Hemorrhagic Stroke, Intracerebral | Phase 4 | Status: NOT_YET_RECRUITING